Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
Zaja
Francesco
F
Vianelli
Nicola
N
Battista
Marta
M
Sperotto
Alessandra
A
Patriarca
Francesca
F
Tomadini
Valentina
V
Filì
Carla
C
Tani
Monica
M
Baccarani
Michele
M
Fanin
Renato
R
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab